Man Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Man Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Buy	+3,270	New	+$408K	﹤0.01%	2128
2025 Q4	–	Sell	-33,329	Closed	-$3.34M	–	2507
2025 Q3	$3.34M	Buy	+33,329	New	+$3M	0.01%	1233
2024 Q3	–	Sell	-6,190	Closed	-$574K	–	2238
2024 Q2	$574K	Buy	+6,190	New	+$555K	﹤0.01%	1653
2024 Q1	–	Sell	-100,653	Closed	-$8.99M	–	2297
2023 Q4	$8.99M	Buy	+100,653	New	+$7.47M	0.03%	703
2023 Q1	–	Sell	-11,396	Closed	-$946K	–	2272
2022 Q4	$946K	Buy	+11,396	New	+$923K	﹤0.01%	1334
2018 Q3	–	Sell	-9,298	Closed	-$885K	–	2243
2018 Q2	$885K	Buy	+9,298	New	+$855K	﹤0.01%	1644

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Man Group's XBI Position: Q1 2026 in Review

Man Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 3,270 shares worth $418K. The stake represents ﹤0.01% of the portfolio and ranks #2128 among its holdings. This is a return to the name: Man Group previously reported a position in XBI as recently as Q3 2025.

Man Group first reported a position in XBI in Q2 2018 and has held it in 6 quarters since. The position peaked at $8.99M in Q4 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Man Group held 3,270 shares of State Street SPDR S&P Biotech ETF worth $418K as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Man Group position in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2128 holding.
Man Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 6 quarters since.
Man Group's State Street SPDR S&P Biotech ETF position peaked at $8.99M in Q4 2023.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.